Publication: Analysis of Retinal Peripapillary Segmentation in Early Alzheimer’s Disease Patients
Loading...
Official URL
Full text at PDC
Publication Date
2015-06-08
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Hindawi Publising Corp.
Citations
Exportar
Abstract
Decreased thickness of the retinal nerve fiber layer (RNFL) may reflect retinal neuronal-ganglion cell death. A decrease in the RNFL has been demonstrated in Alzheimer’s disease (AD) in addition to aging by optical coherence tomography (OCT). Twenty-three mild-AD patients and 28 age-matched control subjects with mean Mini-Mental State Examination 23.3 and 28.2, respectively, with no ocular disease or systemic disorders affecting vision, were considered for study. OCT peripapillary and macular segmentation thickness were examined in the right eye of each patient. Compared to controls, eyes of patients with mild-AD patients showed no statistical difference in peripapillary RNFL thickness (P>0.05); however, sectors 2, 3, 4, 8, 9, and 11 of the papilla showed thinning, while in sectors 1, 5, 6, 7, and 10 there was thickening. Total macular volume and RNFL thickness of the fovea in all four inner quadrants and in the outer temporal quadrants proved to be significantly decreased (P<0.01). Despite the fact that peripapillary RNFL thickness did not statistically differ in comparison to control eyes, the increase in peripapillary thickness in our mild-AD patients could correspond to an early neurodegeneration stage and may entail the existence of an inflammatory process that could lead to progressive peripapillary fiber damage.
Description
Copyright © 2015 Elena Salobrar-Garcia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
UCM subjects
Unesco subjects
Keywords
Citation
[1] D. Hirtz, D. J. Thurman, K. Gwinn-Hardy, M. Mohamed, A. R. Chaudhuri, and R. Zalutsky, “How common are the ‘common’ neurologic disorders?” Neurology, vol. 68, no. 5, pp. 326–337, 2007.
[2] R. Brookmeyer, E. Johnson, K. Ziegler-Graham, and H. M. Arrighi, “Forecasting the global burden of Alzheimer’s disease,” Alzheimer’s and Dementia, vol. 3, no. 3, pp. 186–191, 2007.
[3] J. L. Cummings, H. V. Vinters, G. M. Cole, and Z. S. Khachaturian, “Alzheimer’s disease,” Neurology, vol. 51, no. 1, supplement 1, pp. S2–S17, 1998.
[4] B. J. Small, E. Gagnon, and B. Robinson, “Early identification of cognitive deficits: preclinical Alzheimer’s disease and mild cognitive impairment,” Geriatrics, vol. 62, no. 4, pp. 19–23, 2007.
[5] S. J. McKinnon, “Glaucoma: ocular Alzheimer’s disease?” Frontiers in Bioscience, vol. 8, pp. s1140–s1156, 2003.
[6] K. Chiu, K. So, and R. C. Chang, “Progressive neurodegeneration of retina in Alzheimer’s disease—are